ANI Pharmaceuticals, Inc. (ANIP) Stock Price

ANIPStock
$72.8321.29%52W
Market Cap$1.67B
P/E22.03x
PEG Ratio
Div yield
Beta0.50

ANIP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-16.98%
Price vs S&P 500 (4W)-10.57%
VGM Score61.49
P/E Ratio (Annual)22.03x

ANIP Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026$2.04$2.21+8.22%(+$0.17)
Q1 2026$1.30$2.05+57.77%(+$0.75)
Q4 2025$1.98$2.33+17.85%(+$0.35)
Q3 2025$1.77$2.04+15.25%(+$0.27)
Q2 2025$1.42$1.80+26.77%(+$0.38)

ANIP Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.21
4.21
4.31
4.21

Industry Peers — Pharmaceuticals(570)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ANIPANI Pharmaceuticals, Inc.
BAC$72.83
LLYEli Lilly & Co.DBC$1174.61
JNJJohnson & JohnsonDCB$268.04
ABBVABBVIE INC.DCB$255.48
MRKMerck & Co., Inc.DCB$148.35
NVSNovartis AGCCC$153.81
AZNAstraZeneca PLCCBC$162.70
NVONovo-Nordisk A/SBCC$45.61
ABTAbbott LaboratoriesCCC$112.47
PFEPfizer Inc.CDB$27.96
VRTXVertex Pharmaceuticals IncDCB$541.69

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals manufactures and markets generic prescription medications, specializing in narcotics, hormones, steroids, and complex formulations including extended-release and combination products. The company operates two business segments—Rare Diseases and Brands, Generics, and Others—with primary operations in the United States and a smaller Canadian presence.